Combination with potassium‐sparing diuretics vs monotherapy
Serious adverse events · people with primary hypertension
It is very uncertain whether combination with potassium‐sparing diuretics changes serious adverse events compared with monotherapy (very low certainty).
1 finding from 1 review
- First‐line combination therapy versus first‐line monotherapy for primary hypertension 2020 · Cochrane Headline outcomes onlyRR 0.72 [0.1, 5.04]1 study · 200 participantsVery low